Cabot Corporation
Rank #301ValueCBT · NYSE · Basic Materials
Cabot Corporation (CBT) — Rank #301 by gross profitability (GP/assets 0.24) · ROE 20.6% · Piotroski F-Score 6 / 9.
As-of 2026-09-15 · CIK 0000016040 · all metrics point-in-time as of the filing date.
About
Cabot Corporation operates as a specialty chemicals and performance materials company.
Show moreShow less
It operates through two segments, Reinforcement Materials and Performance Chemicals. The company offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions. It also provides specialty carbons for use in inks, coatings, plastics, adhesives, toners, batteries, and displays; conductive additives and fumed alumina used in lead acid and lithium-ion batteries for electric vehicles; fumed silica used in adhesives, sealants, cosmetics, batteries, inks, toners, silicone elastomers, coatings, polishing slurries, and pharmaceuticals; and fumed alumina for use in various products, including inkjet media, lighting, coatings, cosmetics, and polishing slurries. In addition, it offers aerogel, a hydrophobic, silica-based particle to use in various thermal insulation and specialty chemical applications; masterbatch and conductive compound products that are used in automotive, industrial, packaging, infrastructure, agriculture, consumer products, and electronics industries; and inkjet colorants for inkjet printing applications, as well as carbon nanotubes and fumed metal oxides. The company sells its products through distributors and sales representatives in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
Cabot Corporation was founded in 1882 and is headquartered in Boston, Massachusetts.
- Industry
- Specialty Chemicals
- Sector
- Basic Materials
- State
- DE
- Filer Category
- Large accelerated filer
- Fiscal Year End
- September 30
- Website
- cabotcorp.com
Price History
Company Snapshot
P/E and dividend yield are the primary valuation lenses for mature businesses.
Market Cap
$4.12B
P/E (annual)
13.3
P/S (annual)
1.1
P/B
2.6
P/OCF (annual)
6.2
Shareholder Yield
5.0%
Employees
4,064
Industry
Specialty Chemicals
Exchange
NYSE
Signal Flags
Quality Profile
Profitability
1/1 passSafety
1/1 passCash Flow
3/3 passGrowth
1/2 passTerry Smith quality gate
Passes 2/5 Terry Smith thresholdsWhat Growth Is Priced In
Implied revenue growth (10Y)
-0.4%
The annual FCF growth rate today's price requires over a 10-year horizon (discount rate 10%, terminal growth 2.5%).
Buyback tailwind: -2.7% — per-share value needs a total required return of -3.1% once share-count change is priced in.
vs. own 6-year median revenue growth: -2.7%
Cost-of-equity sensitivity (implied growth at different discount rates)
r = 8%
-4.2%
r = 10% (base)
-0.4%
r = 12%
2.9%
Net debt / market cap: 23.6%
Valuation History
Current multiple vs historical range at each filing date. Band spans 25th-75th percentile.
P / E
Price / diluted EPS
P / S
Price / revenue per share
P / B
Price / book value per share
P / GP
Price / gross profit per share
P / FCF
Price / free cash flow per share
Dividend yield and payout ratio are the primary reads at this stage (trailing P/E — see valuation above).
Profitability
Gross profitability (GP / assets)
0.24
Primary signal (Novy-Marx).
58th pctl of 34 SIC 28 peers
Return on equity
20.6%
Gross margin
25.3%
18th pctl of 34 SIC 28 peers
Revenue growth (YoY)
-7.0%
Gross margin improving
Margin trend vs prior year.
Operating Leverage
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Revenue vs COGS | ||||
| Revenue vs OpEx | ||||
| Op. Income vs Revenue |
Growth
Revenue CAGR (3Y)
-4.9%
Revenue CAGR (5Y)
7.3%
Earnings CAGR (3Y)
16.6%
FCF CAGR (3Y)
—
Anti-fragile safety
Balance-sheet safety
Composite anti-fragile check.
Debt / equity
1.29
23rd pctl of 31 SIC 28 peers (best = lowest)
Current ratio
1.47×
12th pctl of 34 SIC 28 peers
Quick ratio
—
Net cash
-$1.02B
Cash & equivalents minus total debt.
Recession resistance
Revenue through recessions
Worst single-year YoY revenue decline, 17 years of history
Cash-flow health
Free cash flow
$391.00M
Operating cash flow minus capex.
Positive free cash flow
FCF / net income
0.18
Cash-backing of earnings.
FCF/NI divergence
Unfavorable divergence (yellow flag).
Accruals healthy
Cash-backed earnings.
SBC / revenue
0.6%
Stock-based comp intensity.
Dividend safety
Composite score
3.8 / 5
Piotroski F-Score
F-Score
6 / 9
Fundamental-strength score (0-9).